GenMedicn Biopharma

Series-A
genmedicn.com Biotech & Healthcare Nanjing, China
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Oct 7, 2026
Investors 6 Backers
Decision Makers Profile Active

About GenMedicn Biopharma

GenMedicn is a gene therapy drug development company dedicated to popularizing gene therapy drugs to normalized application scenarios.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Nanjing, China
Tracked Since Oct 10, 2026

Web & Domain Identity

Official Website genmedicn.com
Domain Registered Date Jun 23, 2018

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Series-A announced

    Backed by Huade Science and Technology, Broadcom Capital

  2. Milestone

    Website domain registered

    genmedicn.com

Investors & Backers

6
Broadcom Capital
Enran Chuangtou
Huade Science and Technology
Kangyuan Huiying
Longmen Capital
Puhua Capital

Funding History

1 Round
Series-A equity · Oct 7, 2026

Round backers: Huade Science and Technology, Broadcom Capital, Enran Chuangtou, Kangyuan Huiying, Longmen Capital

Undisclosed

Founders & Leadership

3

Huang Yue

Founder

Work email & phone locked Unlock →

Tung Wen-chi

Founder

Work email & phone locked Unlock →

Zhang Yip

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts